Peptide record

TPDB04813

Antibacterial Anticancer Antifungal Antiparasitic standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB04813
Antibacterial Anticancer Antifungal Antiparasitic
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GNGVLKTISHECNMNTWQFLFTCC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C119H180N32O35S4
ARDPY
NCT
2747.17
6.91
2
1
8
-0
0.77
0.087
60.83
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5625
2.05
11
Residue Composition
number
0
A
0
R
3
N
0
D
3
C
1
E
1
Q
2
G
1
H
1
I
2
L
1
K
1
M
2
F
0
P
1
S
3
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 3 D: 0 C: 3 E: 1 Q: 1 G: 2 H: 1 I: 1 L: 2 K: 1 M: 1 F: 2 P: 0 S: 1 T: 3 W: 1 Y: 0 V: 1
Chemical Descriptors
24 reviewed residue count
C119H180N32O35S4 sequence-only estimate (linear, free termini)
2747.17 sequence-only estimate (linear, free termini)
6.91 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
0.77 sequence-only estimate (linear, free termini)
0.087 sequence-only estimate (linear, free termini)
Evidence Records 33 records
Evidence 1 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

B. longum ATCC 15707

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavu
Evidence 2 Activity

Activity

MIC
Antibacterial
32.5 UG/ML

Target

E. contortum ATCC 25540

Source & Reference

dbAMP DRAMP

Other

Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringen
Evidence 3 Activity

Activity

MIC
Antibacterial
32.5 µg/mL

Target

R. obeum ATCC 29174

Source & Reference

dbAMP DRAMP

Other

ve against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile ser
Evidence 4 Activity

Activity

MIC
Antibacterial
75 µg/mL

Target

R. gnavus ATCC 29149

Source & Reference

dbAMP DRAMP

Other

5 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. diffi
Evidence 5 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

Clostridium perfringens CpA

Source & Reference

dbAMP DRAMP

Other

C 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML
Evidence 6 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

Clostridioides difficile serogroup A B-1

Source & Reference

dbAMP DRAMP

Other

(MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML),
Evidence 7 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

Clostridioides difficile serogroup C C253

Source & Reference

dbAMP DRAMP

Other

5 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (
Evidence 8 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

Clostridioides difficile serogroup S3

Source & Reference

dbAMP DRAMP

Other

. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75
Evidence 9 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

C. botulinum

Source & Reference

dbAMP DRAMP

Other

, C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml).
Evidence 10 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

C. bifermentans

Source & Reference

dbAMP DRAMP

Other

53 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021
Evidence 11 Activity

Activity

MIC
Antibacterial
75 UG/ML

Target

B. cereus Z4222

Source & Reference

dbAMP DRAMP

Other

group S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

B. longum ATCC 15707

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavu
Evidence 13 Activity

Activity

MIC
Antifungal
32.5 UG/ML

Target

E. contortum ATCC 25540

Source & Reference

dbAMP DRAMP Antifungipept

Other

Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringen
Evidence 14 Activity

Activity

MIC
Antifungal
32.5 µg/mL

Target

R. obeum ATCC 29174

Source & Reference

dbAMP DRAMP Antifungipept

Other

ve against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile ser
Evidence 15 Activity

Activity

MIC
Antifungal
75 µg/mL

Target

R. gnavus ATCC 29149

Source & Reference

dbAMP DRAMP Antifungipept

Other

5 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. diffi
Evidence 16 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

Clostridium perfringens CpA

Source & Reference

dbAMP DRAMP Antifungipept

Other

C 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML
Evidence 17 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

Clostridioides difficile serogroup A B-1

Source & Reference

dbAMP DRAMP Antifungipept

Other

(MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML),
Evidence 18 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

Clostridioides difficile serogroup C C253

Source & Reference

dbAMP DRAMP Antifungipept

Other

5 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (
Evidence 19 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

Clostridioides difficile serogroup S3

Source & Reference

dbAMP DRAMP Antifungipept

Other

. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75
Evidence 20 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

C. botulinum

Source & Reference

dbAMP DRAMP Antifungipept

Other

, C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml).
Evidence 21 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

C. bifermentans

Source & Reference

dbAMP DRAMP Antifungipept

Other

53 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021
Evidence 22 Activity

Activity

MIC
Antifungal
75 UG/ML

Target

B. cereus Z4222

Source & Reference

dbAMP DRAMP Antifungipept

Other

group S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021
Evidence 23 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

B. longum ATCC 15707

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavu
Evidence 24 Activity

Activity

MIC
Antiparasitic
32.5 UG/ML

Target

E. contortum ATCC 25540

Source & Reference

DRAMP

Other

Active against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringen
Evidence 25 Activity

Activity

MIC
Antiparasitic
32.5 µg/mL

Target

R. obeum ATCC 29174

Source & Reference

DRAMP

Other

ve against B. longum ATCC 15707 (MIC 75 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile ser
Evidence 26 Activity

Activity

MIC
Antiparasitic
75 µg/mL

Target

R. gnavus ATCC 29149

Source & Reference

DRAMP

Other

5 UG/ML), E. contortum ATCC 25540 (MIC 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. diffi
Evidence 27 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

Clostridium perfringens CpA

Source & Reference

DRAMP

Other

C 32.5 UG/ML), R. obeum ATCC 29174 (MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML
Evidence 28 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

Clostridioides difficile serogroup A B-1

Source & Reference

DRAMP

Other

(MIC 32.5 ug/ml), R. gnavus ATCC 29149 (MIC 75 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML),
Evidence 29 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

Clostridioides difficile serogroup C C253

Source & Reference

DRAMP

Other

5 ug/ml), C. perfringens CpA (MIC 75 UG/ML), C. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (
Evidence 30 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

Clostridioides difficile serogroup S3

Source & Reference

DRAMP

Other

. difficile serogroup A B-1 (MIC 75 UG/ML), C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75
Evidence 31 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

C. botulinum

Source & Reference

DRAMP

Other

, C. difficile serogroup C C253 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml).
Evidence 32 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

C. bifermentans

Source & Reference

DRAMP

Other

53 (MIC 75 UG/ML), C. difficile serogroup S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021
Evidence 33 Activity

Activity

MIC
Antiparasitic
75 UG/ML

Target

B. cereus Z4222

Source & Reference

DRAMP

Other

group S3 (MIC 75 UG/ML), C. botulinum (MIC 75 UG/ML), C. bifermentans (MIC 75 UG/ML), and B. cereus Z4222(MIC 75 UG/ML), TZ415 (mic 75 ug/ml). Updated 7/2021